SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Trading Update

6 Jul 2020 07:00

RNS Number : 0478S
Sabien Technology Group PLC
06 July 2020
 

6 July 2020

Sabien Technology Group plc

("Sabien" or the "Company")

Trading Update

The Covid-19 pandemic has affected the entire global economy and Sabien has not escaped its impact. However, in spite of this unprecedented disruption, Sabien's revenues doubled in the second half of the financial year compared to the first half. This brings total sales (unaudited) for the year to approximately £460,000 (FY19: £1,379,000). The decrease in full year sales, while disappointing, is explained by last year's revenues including an exceptional order of £846,375 and by three months of lost sales due to the Covid lockdown in this period.

However, the Board believes that first half sales represent a "low watermark" after several years of diminishing performance by the previous Board and management team. Since the new management team has taken charge earlier this year, sales prospects are demonstrably strengthening, and consistent year-on-year growth is expected as the Company transitions into a more realisable go-to market strategy based on an enhanced product and service proposition.

In addition, the Board has sought to protect shareholder value in challenging market conditions by placing a focus on cash management. During the year cash in the bank has increased to £777,848 at 30 June 2020 (30 June 2019: £738,000; 30 June 2018: £9,000). This includes a Covid business interruption loan of £181,000 from NatWest Bank received on 25 June.

While Covid uncertainty has made it impossible to achieve a profitable performance this year, costs have been tightly controlled within the operating business as follows:

· Following, the announcement of major new strategic shareholder on 3 September 2019, the management team has been restructured with the departure of the Alan O'Brien, CEO, (announced 5/11/19) and David Bakst, Managing Director (announced (29/5/20). Until further notice these functions will filled by Executive Chairman, Richard Parris. These changes will contribute an annual saving on the operating company payroll of more than £200,000 from 1 June 2020.

· The Board placed 85% of the workforce on Covid-19 furlough from 31 March 2020. This has mitigated payroll expenses for 25% of the financial year and has helped to preserve jobs and expertise. During this period the Company was unable gain access to customer sites to undertake any installations but background sales and planning tasks to have been undertaken to the extent possible using non-furloughed staff.

The Company has recently started a development project to "cloud enable" its existing M2G user base (up to circa 10,500 units). This will enable upselling opportunities to existing customers and provide a source of new subscription revenue within the next period. For the first time in the Company's history this will enable recurring revenues to be generated from its large installed base. It is anticipated this will also reduce the time to secure new orders and support an international channel partner programme. Early revenues from this new Cloud service are expected before the end of 2020.

Operationally, Sabien is planning a strong start to the new financial period with a backlog of more than 300 M2G units to install and a confirmed order book of approximately £140,000. Commencing 16 June 2020, staff are being phased back from furlough leave to enable the Company to start to install backlogged units. The limiting factor is regaining access to customer sites which have been in lockdown since March. It is likely that full operations will restored within 3 months, with a new look business focused increasingly on indirect selling through channel partners in the UK and the US.

Richard Parris, Chairman, said: "The Sabien operating business is entering the new financial year in good shape to deliver year-on-year growth, relative to FY2020. This is a direct result of the Board's restructuring of the management and sales teams. During FY2021 and beyond we are expecting a sales bounce from (1) a post-Covid investment focus on green technology and (2) recessionary sentiments across the economy that will place a immediate customer emphasis on cost reduction programmes with short payback windows. I believe Sabien is now well placed to benefit from both of these macro trends and, in conjunction with our cost control measures, the Company is in a strong position for a return to profitability. The Board thanks Sabien staff for their support and forbearance during the difficult time of furlough and we look forward to welcoming you back over the coming weeks."

 

For further information:

Sabien Technology Group plc

Richard Parris, Chairman

SPARK Advisory Partners Limited (Nominated Adviser)

Neil Baldwin / Matt Davis

Peterhouse Capital Limited (Broker)

Duncan Vasey/ Lucy Williams 

+44 20 7993 3700

 

+44 203 368 3550 

 

+44 207 469 0930

A copy of this announcement will be available from the Company's website at www.sabien-tech.co.uk

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKNBQABKDNOK
Date   Source Headline
11th Jun 20267:00 amRNSIssue of shares to directors & broker
2nd Jun 20267:00 amRNSProposed balance sheet strengthening & M2G update
29th May 20265:00 pmRNSTotal Voting Rights
21st May 20267:00 amRNSProposed Commercial Partnership & Investment
20th May 20266:22 pmRNSSettlement of Historical Contract
31st Mar 20267:00 amRNSHalf-year Report for the 6 months to 31 Dec 2025
10th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Jan 20265:30 pmRNSHolding(s) in Company
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
9th Dec 20251:20 pmRNSResult of Annual General Meeting
9th Dec 20257:00 amRNSAGM Statement & Trading Update
19th Nov 20257:00 amRNSProposed Strategic Agreement with COF
13th Nov 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
10th Nov 20257:00 amRNSNew Factoring Facility
5th Nov 202512:01 pmRNSAppointment of Corporate Broker
2nd Oct 202512:06 pmRNSFurther update on Sabien, b.grn & related matters
19th Sep 20257:00 amRNSTrading Update
31st Jul 20254:59 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSYear End Trading Update
30th Jun 20252:53 pmRNSIssue of shares to directors
23rd Jun 20254:28 pmRNSHolding(s) in Company
17th Mar 20257:00 amRNSHalf-year Report for the 6 months to 31 Dec 2024
6th Feb 202511:43 amRNSUpdate in relation to Aeristech Limited
27th Jan 20257:00 amRNSTrading update - acceleration of new M2G orders
31st Dec 202412:30 pmRNSTotal Voting Rights
19th Dec 202410:51 amRNSResult of Annual General Meeting
19th Dec 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
28th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSIssue of shares to non-executive directors
18th Nov 20247:00 amRNSFinal Results & Annual Report & Accounts for 2024
11th Nov 20247:00 amRNSNew M2G Cloud Connection System Order
17th Oct 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
30th Sep 20245:00 pmRNSTotal Voting Rights
26th Sep 20244:21 pmRNSDirector/PDMR Shareholding
19th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:30 pmRNSAdmission of New Shares & Total Voting Rights
29th Aug 20244:00 pmRNSUpdate on Admission of New Ordinary Shares
20th Aug 20247:00 amRNSRelated Party Funding
8th Jul 20248:15 amRNSTrading Statement
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.